Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

  • Jianguo Tao
  • Eduardo Sotomayor

Part of the Cancer Growth and Progression book series (CAGP, volume 14)

Table of contents

  1. Front Matter
    Pages i-vi
  2. Jianguo Tao, Chih-Chi Andrew Hu
    Pages 1-20
  3. Alyssa Bouska, SharathKumar Bagvati, Javeed Iqbal, Basem M. William, Wing C. Chan
    Pages 21-42
  4. Javier Pinilla-Ibarz, Chih-Chi Andrew Hu
    Pages 43-52
  5. Lubomir Sokol, Brady E. Betran
    Pages 99-111
  6. Bijal Shah, Peter Martin, Jianguo Tao, Eduardo M. Sotomayor
    Pages 113-135
  7. Ádám Jóna, Árpád Illés, Anas Younes
    Pages 181-202
  8. Grant E. Nybakken, Adam Bagg
    Pages 203-240
  9. Kapil Bhalla, Celalettin Ustun, Warren Fiskus
    Pages 277-314
  10. Vu Duong, Jeffrey Lancet
    Pages 315-348
  11. Owen O. Connor, Salvia Jain, Jasmine Zain
    Pages 349-372
  12. Mithun Vinod Shah, Thomas P. Loughran Jr.
    Pages 373-393
  13. Yizhuo Zhang, Shanqi Guo, Haifeng Zhao
    Pages 395-418
  14. Back Matter
    Pages 419-426

About this book


In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies. 


Leukemia Lymphoma Molecular Pathogenesis Targeted Therapy

Editors and affiliations

  • Jianguo Tao
    • 1
  • Eduardo Sotomayor
    • 2
  1. 1.Research Institute, Department of Hematopathology andH. Lee Moffitt Cancer Center &TampaUSA
  2. 2.Research Institute, Department of Malignant HematologyH. Lee Moffitt Cancer Center &TampaUSA

Bibliographic information

  • DOI
  • Copyright Information Springer Science+Business Media Dordrecht 2012
  • Publisher Name Springer, Dordrecht
  • eBook Packages Medicine
  • Print ISBN 978-94-007-5027-2
  • Online ISBN 978-94-007-5028-9
  • Buy this book on publisher's site